Avalon GloboCare Corp. (ALBT)

Compare

3.6000

+1.3600

(+60.71%)

At close: November 5 at 4:00 PM EST

3.2400

-0.36

(-10.00%)

Pre-Market: 8:21 AM EST

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Dr. David K. Jin M.D., Ph.D.	CEO, President & Director	330k	--	1968
Ms. Luisa Ingargiola	Chief Financial Officer	350k	--	1967
Ms. Meng Li	COO & Secretary	280.24k	--	1978

4400 Route 9 South

Suite 3100

Freehold, NJ 07728

United States

732 780 4400 https://www.avalon-globocare.com

Sector:?: Real Estate
Industry:?
Full Time Employees:?: 4

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.

Avalon GloboCare Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

August 19, 2024 at 8:00 PM UTC

Avalon GloboCare Corp. Earnings Date

November 1, 2024 at 12:00 AM UTC